August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden Statement Opposing Jamieson Greer's Nomination for U.S. Trade Representative
- Democrats Urge Republicans Against Using Medicaid To Bankroll Tax Cuts For The Rich At The Expense Of Working Families, Seniors And Americans With Disabilities
- Wyden Sounds the Alarm on DOGE Accessing Social Security Systems Containing Americans’ Sensitive Personal and Financial Information
- Responding to Evidence of a Treasury Cover-Up, Wyden Demands Bessent Come Clean on Musk Infiltration of Treasury Payment Systems
- Democratic Health Leaders Call for Inspector General Investigation into Elon Musk’s Access to Americans’ Sensitive Health Care information